Business Context and Reporting Period
This Form 8-K, dated November 8, 2018, reports that CommScope Holding Company, Inc. (CommScope) entered into a definitive agreement to acquire ARRIS International plc (ARRIS). The filing details the terms of the Bid Conduct Agreement, financing arrangements, and related equity issuance.
Key Financial Metrics and Transaction Terms
- Acquisition Price: $31.75 per ARRIS ordinary share.
- Financing Structure:
- Debt Financing: Up to $5.5 billion in senior secured term loans, up to $750 million in asset-based revolving credit, and up to $1.0 billion in senior unsecured notes or bridge loans.
- Equity Financing: $1.0 billion investment from Carlyle Partners VII S1 Holdings, L.P. via Series A Convertible Preferred Stock.
- Preferred Stock Terms: 1,000,000 shares at $1,000 per share; 5.5% cumulative dividend (increasing to 8.0% if unpaid); convertible at $27.50 per share; liquidation preference of $1,000 per share.
- Termination Fees:
- ARRIS to pay CommScope: $58 million (reduced to $29 million if an alternative proposal is consummated within 12 months).
- CommScope to pay ARRIS (Reverse Termination Fee): $250 million (triggered by breach, financing failure, or antitrust prohibition).
Material Changes and Transaction Conditions
The transaction is subject to several closing conditions, including ARRIS shareholder approval, sanction by the High Court of Justice of England and Wales, and regulatory approvals in the U.S., EU, Chile, Mexico, Russia, and South Africa. The agreement includes a "Long Stop Termination Date" of June 30, 2019, subject to three one-month extensions. ARRIS is restricted from soliciting alternative proposals unless a "Superior Proposal" is received that is reasonably likely to be consummated.
Outlook, Risks, and Management Commentary
CommScope intends to fund the transaction using cash on hand, equity issuance, and new debt financing. There is no financing condition to the transaction; however, failure to secure financing may trigger the $250 million reverse termination fee. Key risks identified include the failure to obtain regulatory approvals, integration challenges, unanticipated costs, and potential impacts on customer and employee relationships. The filing includes standard forward-looking statement disclaimers regarding future performance and synergies.
Investor Verification Checklist
- Verify the status of regulatory approvals required in the U.S., EU, and other specified jurisdictions.
- Confirm the final terms of the debt commitment letters and the successful closing of the $1.0 billion Carlyle investment.
- Monitor the timeline for the High Court of Justice sanction and ARRIS shareholder vote.
- Review the specific terms of the Series A Convertible Preferred Stock regarding dividend accrual and conversion caps (19.9% of outstanding common stock).
- Assess the potential impact of the $250 million reverse termination fee on CommScope's liquidity if the deal fails due to antitrust or financing issues.